# Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances

> **NCT03164135** · NA · UNKNOWN · sponsor: **Affiliated Hospital to Academy of Military Medical Sciences** · enrollment: 5 (estimated)

## Conditions studied

- HIV-1-infection

## Interventions

- **GENETIC:** CCR5 gene modification

## Key facts

- **NCT ID:** NCT03164135
- **Lead sponsor:** Affiliated Hospital to Academy of Military Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-30
- **Primary completion:** 2019-05-20
- **Final completion:** 2021-05-20
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2017-05-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03164135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03164135, "Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03164135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*